Chargement en cours...

Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy that is best treated in a multidisciplinary fashion using surgery, chemotherapy, and radiation. Adjuvant chemotherapy has shown to have a significant survival benefit in patients with resected PDAC. However, up to 50% of patients fa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Gastroenterol
Auteurs principaux: Hamad, Ahmad, Brown, Zachary J, Ejaz, Aslam M, Dillhoff, Mary, Cloyd, Jordan M
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8316910/
https://ncbi.nlm.nih.gov/pubmed/34366611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i27.4383
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!